Clinical Trials Sponsored by Annesofie Faurschou
Total 2 results
-
Annesofie FaurschouUniversity of CopenhagenCompleted
-
Annesofie Lunde JensenCompletedType1 Diabetes MellitusDenmark
Sponsors and Collaborators
- UZ Leuven, campus Pellenberg (Belgium)
- Advanced Life Solutions
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Fogarty International Center of the National Institute of Health
- Custom Pharmaceuticals Limited
- JMI Laboratories
- Physip S.A
- Hazelden Betty Ford Foundation
- Prof. Jacques SCHRENZEL
- Dr. Praveen B.H
- Nestlé Health Science Belgium
- IN-JET APS
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- The Fred Hollows Foundation, Australia
- Pedro Gamito
- Stannah Stairlifts
- Hospital Samaritano Paulista
- Markham Stouffville Hospital
- Familien Hede Nielsens Fond
- Janssen (China) Research & Development Center
- View Full List
Medical Conditions
- Fracture Dislocation of Cervical Spine
- Spine Surgeries
- Painless Hysteroscopy
- Epidemic Hemorrhagic Fever
- Chlamydophila Infections
- Gullian Barre Syndrome
- Closure; Foramen Ovale
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Pulmonary Adenocarcinoma
- Childhood Langerhans Cell Histiocytosis
- Fetus or Neonate Affected by External Version Before Labor
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Predictors of Atrial Fibrillation Recurrences
- Psoriasis, Arthritic
- Endocarditis Infective
- Tay-Sachs Disease Ganglioside
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Ewing's Family Tumors
- Skull Base Neoplasms
- Multisystem Proteinopathy
- View Full List
Drug Interventions
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Adriamycin
- High dose pantoprazole infusion
- Semapimod
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Redifferentiation with retinoid acid
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- EFV +TVA
- Glimepiride
- Estradiol+Drospirenone
- Palliative care group first-line scheme
- Vehicle
- Qingkailing injection 40 ml
- Chemotherapeutic Agent
- Adapalene Gel 0.3%
- Cereport
- Azelastine hydrochloride (BAYR9258)
- Esomeprazole 40mg before
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Neihulizumab
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Bahamas
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Bosnia & Herzegovina
- Contract Research Organizations in Bulgaria
- Contract Research Organizations in Cambodia
- Contract Research Organizations in Guinea
- Contract Research Organizations in Malawi
- Contract Research Organizations in Poland
- Contract Research Organizations in Slovakia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Turkmenistan
- Contract Research Organizations in Türkiye
- CRO list by country